PARP9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.767000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.158800E-01
Normal-vs-Stage2
6.039400E-01
Normal-vs-Stage3
1.423210E-01
Normal-vs-Stage4
3.813600E-01
Stage1-vs-Stage2
9.461000E-01
Stage1-vs-Stage3
1.394950E-01
Stage1-vs-Stage4
5.402000E-01
Stage2-vs-Stage3
2.256600E-01
Stage2-vs-Stage4
5.555200E-01
Stage3-vs-Stage4
5.194600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.592800E-01
Normal-vs-AfricanAmerican
4.539000E-01
Normal-vs-Asian
9.760400E-01
Caucasian-vs-AfricanAmerican
9.397000E-01
Caucasian-vs-Asian
3.115200E-01
AfricanAmerican-vs-Asian
4.854800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.550800E-01
Normal-vs-Female
6.147400E-01
Male-vs-Female
7.119000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.634000E-01
Normal-vs-Age(41-60Yrs)
6.918400E-01
Normal-vs-Age(61-80Yrs)
5.774800E-01
Normal-vs-Age(81-100Yrs)
2.115400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.320200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.264600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.123800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.425600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.332800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.194200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.793500E-02
Normal-vs-Daily Drinker
6.381800E-01
Normal-vs-Weekly Drinker
4.288600E-01
Normal-vs-Occasional Drinker
5.698000E-01
Normal-vs-Social Drinker
9.214000E-01
Non Drinker-vs-Daily Drinker
5.364400E-02
Non Drinker-vs-Weekly Drinker
4.069800E-01
Non Drinker-vs-Occasional Drinker
1.975390E-01
Non Drinker-vs-Social Drinker
9.478200E-02
Daily Drinker-vs-Weekly Drinker
4.998200E-01
Daily Drinker-vs-Occasional Drinker
7.540200E-01
Daily Drinker-vs-Social Drinker
4.544400E-01
Weekly Drinker-vs-Occasional Drinker
7.382400E-01
Weekly Drinker-vs-Social Drinker
2.643800E-01
Occasional Drinker-vs-Social Drinker
3.660800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.503400E-01
Normal-vs-Grade 2
3.826100E-02
Normal-vs-Grade 3
7.169800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.176300E-02
Grade 1-vs-Grade 3
1.082390E-02
Grade 1-vs-Grade 4
2.503400E-01
Grade 2-vs-Grade 3
2.279400E-01
Grade 2-vs-Grade 4
3.826100E-02
Grade 3-vs-Grade 4
7.169800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.274400E-01
Normal-vs-NonDiabetic
6.385000E-01
Diabetic-vs-NonDiabetic
7.040100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.611200E-01
Normal-vs-NoPancreatitis
5.597200E-01
Pancreatitis-vs-NoPancreatitis
9.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.964800E-01
Normal-vs-N1
6.360400E-01
N0-vs-N1
3.211200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.014000E-01
Normal-vs-TP53-NonMutant
7.219000E-01
TP53-Mutant-vs-TP53-NonMutant
4.026200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
